Intellia Therapeutics(DE:38I)
€9.20-0.19 (-2.02%)
DE:38I
Intellia Therapeutics earnings date
€9.20
At close:-0.19 (-2.02%)
Intellia Therapeutics (38I) Q2 2022 Earnings Report
14 Followers
DE:38I Q2 2022 EPS Results
- Actual EPS
- -EUR 1.20
- Consensus EPS
- -EUR 1.18
- Beat/Miss
- Missed by -EUR 0.02
- One Year Ago EPS
- -EUR 0.91
DE:38I Q2 2022 Revenue Results
- Actual Revenue
- EUR 12.68M
- Expected Revenue
- EUR 8.51M
- Beat/Miss
- Beat by +EUR 4.17M
- YoY Revenue Growth
- +114.20%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- Before Open
- Conference Call
- Thursday, August 4, 2022
DE:38I Upcoming Earnings
Intellia Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:38I Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.72- | -0.75 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.72-0.82 | -0.83 | 1.09% (+0.01) | |
| Aug 06, 2026 | 2026 (Q2) | -0.72-0.72 | -0.89 | 18.37% (+0.16) | |
| May 11, 2026 | 2026 (Q1) | -0.82-0.73 | -0.99 | 26.36% (+0.26) | |
| Feb 26, 2026 | 2025 (Q4) | -0.86-0.75 | -1.15 | 34.65% (+0.40) | |
| Nov 06, 2025 | 2025 (Q3) | -0.91-0.83 | -1.21 | 31.34% (+0.38) | |
| Aug 07, 2025 | 2025 (Q2) | -0.92-0.89 | -1.37 | 35.53% (+0.49) | |
| May 08, 2025 | 2025 (Q1) | -1.16-0.99 | -1.01 | 1.79% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -1.20-1.15 | -1.32 | 13.01% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -1.26-1.21 | -1.25 | 2.90% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

